Van Sande J - Search Results

1

Somatic and germline mutations of the TSH receptor gene in thyroid diseases.

Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G. Van Sande J, et al. J Clin Endocrinol Metab. 1995 Sep;80(9):2577-85. doi: 10.1210/jcem.80.9.7673398. J Clin Endocrinol Metab. 1995. PMID: 7673398 Review. No abstract available.

2

Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.

Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J, et al. Duprez L, et al. Among authors: van sande j. Nat Genet. 1994 Jul;7(3):396-401. doi: 10.1038/ng0794-396. Nat Genet. 1994. PMID: 7920658

3

Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid.

Paschke R, Tonacchera M, Van Sande J, Parma J, Vassart G. Paschke R, et al. Among authors: van sande j. J Clin Endocrinol Metab. 1994 Dec;79(6):1785-9. doi: 10.1210/jcem.79.6.7989485. J Clin Endocrinol Metab. 1994. PMID: 7989485

4

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.

Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G. Parma J, et al. Among authors: van sande j. Nature. 1993 Oct 14;365(6447):649-51. doi: 10.1038/365649a0. Nature. 1993. PMID: 8413627

5

Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.

Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G. Parma J, et al. Among authors: van sande j. Mol Endocrinol. 1995 Jun;9(6):725-33. doi: 10.1210/mend.9.6.8592518. Mol Endocrinol. 1995. PMID: 8592518

6

Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.

Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J. Tonacchera M, et al. Among authors: van sande j. J Clin Endocrinol Metab. 1996 Feb;81(2):547-54. doi: 10.1210/jcem.81.2.8636266. J Clin Endocrinol Metab. 1996. PMID: 8636266

7

Activating mutations of the TSH receptor gene cause thyroid diseases.

Vassart G, Van Sande J, Parma J, Tonacchera M, Duprez L, Swillens S, Dumont J. Vassart G, et al. Among authors: van sande j. Ann Endocrinol (Paris). 1996;57(1):50-4. Ann Endocrinol (Paris). 1996. PMID: 8734289 Review.

8

The TSH receptor and thyroid diseases.

Paschke R, Van Sande J, Parma J, Vassart G. Paschke R, et al. Among authors: van sande j. Baillieres Clin Endocrinol Metab. 1996 Jan;10(1):9-27. doi: 10.1016/s0950-351x(96)80266-7. Baillieres Clin Endocrinol Metab. 1996. PMID: 8734449 Review.

9

TSH receptor and disease.

Tonacchera M, Van Sande J, Parma J, Duprez L, Cetani F, Costagliola S, Dumont JE, Vassart G. Tonacchera M, et al. Among authors: van sande j. Clin Endocrinol (Oxf). 1996 Jun;44(6):621-33. doi: 10.1046/j.1365-2265.1996.746567.x. Clin Endocrinol (Oxf). 1996. PMID: 8759174 Review. No abstract available.

10

Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene.

Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G, Parma J. Duprez L, et al. Among authors: van sande j. J Clin Endocrinol Metab. 1997 Jan;82(1):306-8. doi: 10.1210/jcem.82.1.3691. J Clin Endocrinol Metab. 1997. PMID: 8989278 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page